KYMERA THERAPEUTICS
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. It features a proprietary predictive modeling degradation platform with a novel small molecule modality to accelerate the drug discovery designed for disease-causing proteins.
KYMERA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.kymeratx.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
604 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Abata Therapeutics
Abata Therapeutics is a biotech company.
Allay Therapeutics
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Mahana Therapeutics
Mahana Therapeutics is a developer of digital treatments for people living with gastrointestinal conditions.
Neogene Therapeutics
Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Seer
Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Kymera Therapeutics
Redmile Group
Redmile Group investment in Post-IPO Equity - Kymera Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Kymera Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Post-IPO Equity - Kymera Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Post-IPO Equity - Kymera Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Kymera Therapeutics
Solasta Ventures
Solasta Ventures investment in Series C - Kymera Therapeutics
Redmile Group
Redmile Group investment in Series C - Kymera Therapeutics
BlackRock
BlackRock investment in Series C - Kymera Therapeutics
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Kymera Therapeutics
Key Employee Changes
Official Site Inspections
http://www.kymeratx.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.68 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago